Eyebright Medical Technology (Beijing) Co., Ltd. (“Eyebright Medical”; SH Stock Code: 688050) is a National High-tech Enterprise and state-level technologically advanced "Little Giant" enterprises，located in Zhongguancun Science and Technology Park, Beijing, China.

The Company is an innovation-driven ophthalmic medical device manufacturer. Its comprehensive product portfolio spans three major areas of the ophthalmic field: surgical treatment, myopia management, as well as consumer vision care. Anchored by its three core product categories - intraocular lenses, orthokeratology lenses, and contact lenses - the company has strategically expanded its product pipeline to cover the whole vision care life cycle.

Driven by innovation at its core, the company possesses robust research and development capabilities, underpinned by a comprehensive system of research management and a robust innovation incentive mechanism. The company operates the "Ophthalmic Biomaterials and Clinical Technologies" Beijing Municipal Engineering Laboratory, and is a joint laboratory of National Engineering Research Center for Ophthalmic Equipment in China, Eyebright Medical has undertaken numerous national key R&D programs, including China Torch Program Exemplary Project, as well as municipal-level research initiatives in Beijing.

Adhering to the business philosophy of "Innovation as the driving force and quality as the key to survival", the company has leveraged its five proprietary technology platforms, balanced product portfolio, and well-developed distribution network to establish a competitive advantage and entry barriers in China. The company is striding into a world-leading medical enterprise on behalf of China’s "Intelligent Manufacturing" power.